Helen Of Troy Ltd (HELE) · Oct 8, 2026 · Earnings
Beat — Adjusted EPS $0.79 vs ~$0.51 consensus; sales $440.9M vs ~$441.5M
Helen of Troy’s Q2 earnings beat expectations even excluding most tariff refunds, while FY27 adjusted EBITDA, EPS and free-cash-flow guidance all increased.
Helen of Troy is in the stabilization year of a multi-year turnaround: rebuilding brands and organization, improving execution, reducing debt, and shifting investment toward higher-potential products after fiscal 2026’s major impairments. Its stated strategy is to become “better before bigger,” with emphasis on brand reinvestment, operating discipline and balance-sheet repair.
The quarter beat where it mattered. Revenue was effectively in line with expectations at $440.9 million, up 2.1% year over year, but adjusted EPS of $0.79 was well above published expectations around $0.51–$0.52. The EPS beat was not solely a tariff windfall: the company said the quarter received a $4.0 million net pre-tax tariff-refund benefit, worth approximately $0.12 per share, implying roughly $0.67 of adjusted EPS before that benefit.
| Metric | Fiscal 2027 Q2 / Outlook | Comparison | Read |
|---|---|---|---|
| Net sales revenue (Income Statement) | $440.9M | $431.8M prior year; ~$441.5M consensus | Essentially in line |
| Adjusted diluted EPS (Adjusted EPS reconciliation) | $0.79 | $0.59 prior year; ~$0.51–$0.52 consensus | Clear beat |
| Adjusted EBITDA (Financial Highlights) | $49.4M | $36.2M prior year | Up 36.6% |
| FY27 adjusted EBITDA outlook (Outlook table) | $203M–$210M | $190M–$197M prior | Raised |
| FY27 adjusted EPS outlook (Outlook table) | $3.60–$4.15 | $3.25–$3.75 prior | Raised |
| FY27 free-cash-flow outlook (Outlook table) | $120M–$140M | $85M–$100M prior | Raised materially |
Margin recovery is the real operating signal. Gross margin expanded to 52.2% from 44.2%, while adjusted operating income rose 40.9% to $37.9 million and adjusted operating margin reached 8.6%. Tariff refunds helped, but the filing also points to lower promotional spending and operating leverage; those gains were partly absorbed by higher personnel, packaging, marketing and inflation-related costs.
The portfolio is improving unevenly, not broadly repaired. Home & Outdoor delivered 9.2% sales growth and a 12.3% adjusted operating margin, driven by packs, international sales, distribution gains and launches. Beauty & Wellness sales fell 4.5% and its GAAP operating margin was negative 0.5%, with weakness in hair appliances, prestige hair care and water filtration partly offset by heaters, thermometers and nail care. That makes the consolidated beat more dependent on Home & Outdoor and cost recovery than on a clean rebound across the portfolio.
Management raised the earnings and cash framework while leaving the sales story broadly unchanged. The revised sales range is $1.768 billion–$1.822 billion versus $1.759 billion–$1.831 billion previously, so the midpoint is essentially unchanged. The meaningful upgrades are adjusted EBITDA, adjusted EPS, operating cash flow and free cash flow, alongside a lower targeted net leverage ratio of no more than 2.7x versus 3.2x previously. However, planned capital spending also increased to $39 million–$43 million from $30 million–$34 million, and the outlook assumes about $80.5 million of tariff refunds, most of which will be reinvested.
Bottom line: This is a genuine earnings beat with better underlying margins and a substantially stronger cash-and-profit outlook. The turnaround is advancing, but the sales recovery remains concentrated in Home & Outdoor while Beauty & Wellness is still a drag, and tariff-related benefits are doing meaningful work in the upgraded forecast.
Q3 earnings report, likely January 2027
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!